European Journal of Inflammation (Sep 2003)

Topical Vitamin E Acetate for the Treatment of Cheilitis: A Multicentre Experience

  • N. Cassano,
  • M. De Benedittis,
  • M. Petruzzi,
  • M. Carbonara,
  • C. Agnusdei,
  • G. Alessandrini,
  • M. Bellini,
  • A. Callea,
  • M.L. Carriera,
  • C. Coviello,
  • E. Crifò Gasparro,
  • S. Dattola,
  • A. Ferrari,
  • M. Gabellone,
  • M. Gravante,
  • P. Ligori,
  • G. Liguori,
  • A. Mancino,
  • S. Manco,
  • G. Martina,
  • V. Pietrantonio,
  • F. Postorino,
  • A. Saviozzi,
  • G. Schiraldi,
  • M.R. Sodo,
  • R. Stasi,
  • G. Tortora,
  • A. Zoccali,
  • G.A. Vena

DOI
https://doi.org/10.1177/1721727X0300100306
Journal volume & issue
Vol. 1

Abstract

Read online

Treatment of cheilitis is usually difficult and often disappointing. We evaluated the effects of a topical preparation containing vitamin E acetate (VEA® lipogel) in 254 patients (mean age, 29.5) with cheilitis of various nature and etiology, involving the vermilion region and/or the perioral skin. The most frequent form of cheilitis was that induced by oral isotretinoin; other forms were irritant contact dermatitis, atopic cheilitis, and contact allergy. Patients were instructed to apply VEA® lipogel daily; the number of daily applications was modulated on the basis of the severity of symptoms (two or three times a day in the majority of cases). After 4 weeks of treatment, clinical examination showed that the severity of symptoms and signs significantly improved (P<0.001). The response to treatment was reported as particularly rapid by 32% of patients. Patient's assessment of overall effectiveness and acceptability was positive in the majority of cases. Treatment was well tolerated; local adverse reactions were observed in 2.75% of patients and were mostly transient and mild. Our experience suggests that VEA® lipogel is an effective and safe approach to cheilitis. The safety of this preparation is also due to the presence of only a few excipients and the absence of fragrances, preservatives and colouring agents.